trending Market Intelligence /marketintelligence/en/news-insights/trending/wY3P8fEuL-qlu-sy4ahdaQ2 content esgSubNav
In This List

Natera prices $200M common stock offering


Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection


Japan M&A By the Numbers: Q4 2023


Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Natera prices $200M common stock offering

Natera Inc. priced its public offering of 5,714,286 common shares at $35 apiece.

The San Carlos, Calif.-based company also granted underwriters a 30-day option to buy up to an additional 857,142 common shares at the same price.

Gross proceeds from the offering, based on the offering size and per-share price, are expected to reach about $200 million.

The offering is expected to close on Oct. 21.

J.P. Morgan, Morgan Stanley, Cowen and Piper Jaffray are acting as joint book-running managers for the offering, while Baird and Craig-Hallum Capital Group are co-managers.

Natera offers preconception and prenatal genetic testing services. In May, its custom test to detect tumor DNA received breakthrough device designation from the U.S. Food and Drug Administration.